Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allopurinol as a Possible Oxygen Sparing Agent During Exercise in Peripheral Arterial Disease (APOSA-PAD)

This study has been completed.
Sponsor:
Collaborators:
NHS Tayside
British Heart Foundation
Information provided by (Responsible Party):
Alan Robertson, University of Dundee
ClinicalTrials.gov Identifier:
NCT01147705
First received: June 18, 2010
Last updated: March 24, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Publications: